# Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab

> **NCT05737368** · PHASE1 · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 11 (estimated)

## Conditions studied

- Recurrent Glioblastoma

## Interventions

- **RADIATION:** fractionated radiotherapy
- **DRUG:** cadonilimab

## Key facts

- **NCT ID:** NCT05737368
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-28
- **Primary completion:** 2024-02-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05737368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05737368, "Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05737368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*